Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes-Reference-Cited by-同舟云学术

Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes

Published:2019-06-18 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Sayan Mutlay,Yegya-Raman Nikhil,Greco Stephanie H.,Gui Bin,Zhang Andrew,Chundury Anupama,Grandhi Miral S.,Hochster Howard S.,Kennedy Timothy J.,Langan Russell C.,Malhotra Usha,Rustgi Vinod K.,Shah Mihir M.,Spencer Kristen R.,Carpizo Darren R.,Nosher John L.,Jabbour Salma K.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference157 articles.

1. Cancer statistics, 2016;Siegel;CA,2016

2. 2017

3. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis;Gomaa;World J Gastroenterol.,2008

4. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology (Baltimore, Md).,2018

5. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma;Forner;Hepatology (Baltimore, Md).,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01

2. Proton Radiation Therapy;Fundamentals of Radiation Oncology;2024

3. Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research;Current Oncology;2023-07-05

4. Lipo-MGN nanoparticle hypoxia attenuation-mediated single-dose radiotherapy- and pH/ROS-responsive T1 contrast magnetic resonance imaging in hepatocellular carcinoma;Cancer Nanotechnology;2023-05-16

5. Lipo-MGN Nanoparticle Hypoxia Attenuation Mediated Single-dose Radiotherapy and pH/ROS Responsive T1 Contrast Magnetic Resonance Imaging in Hepatocellular Carcinoma;2022-10-18